Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Diamond

Showing results (951-960 of 1,028) with videos related to

Pageof 103
Sort By:
Virology|May 22, 2012
Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesisAngela L Rasmussen, I-Ming Wang, Margaret C Shuhart, et al.
Environmental Science & Technology|July 13, 2026
Aligning Horizon Scanning Approaches with Differing Needs and Topics at the Science-Policy Interface on Chemicals, Waste, and PollutionGabriel Sigmund, Ricardo O Barra, Michael G Bertram, et al.
Environmental Science & Technology|November 14, 2023
Accelerating Environmental Research to Achieve Sustainable Development GoalsJames R Mihelcic, Ricardo O Barra, Bryan W Brooks, et al.
Blood|May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes diseaseOussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Environmental Science & Technology|February 22, 2023
Environmental Research Addressing Sustainable Development GoalsJames R Mihelcic, Ricardo O Barra, Bryan W Brooks, et al.
Haematologica|December 22, 2022
Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods studyAnne S Reiner, Dana Bossert, Justin J Buthorn, et al.
Blood|May 23, 2014
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseEli L Diamond, Lorenzo Dagna, David M Hyman, et al.
Blood Advances|October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasmsBenjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
The Lancet. HIV|February 28, 2026
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trialJürgen K Rockstroh, Sheetal Kassim, Roger Paredes, et al.
Science Translational Medicine|October 25, 2023
Genetic vulnerability to Crohn's disease reveals a spatially resolved epithelial restitution programToru Nakata, Chenhao Li, Toufic Mayassi, et al.
Pageof 103

Showing results (951-960 of 1,028) with videos related to

Sort By:
Pageof 103
Virology|May 22, 2012
Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesisAngela L Rasmussen, I-Ming Wang, Margaret C Shuhart, et al.
Environmental Science & Technology|July 13, 2026
Aligning Horizon Scanning Approaches with Differing Needs and Topics at the Science-Policy Interface on Chemicals, Waste, and PollutionGabriel Sigmund, Ricardo O Barra, Michael G Bertram, et al.
Environmental Science & Technology|November 14, 2023
Accelerating Environmental Research to Achieve Sustainable Development GoalsJames R Mihelcic, Ricardo O Barra, Bryan W Brooks, et al.
Blood|May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes diseaseOussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Environmental Science & Technology|February 22, 2023
Environmental Research Addressing Sustainable Development GoalsJames R Mihelcic, Ricardo O Barra, Bryan W Brooks, et al.
Haematologica|December 22, 2022
Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods studyAnne S Reiner, Dana Bossert, Justin J Buthorn, et al.
Blood|May 23, 2014
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseEli L Diamond, Lorenzo Dagna, David M Hyman, et al.
Blood Advances|October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasmsBenjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
The Lancet. HIV|February 28, 2026
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trialJürgen K Rockstroh, Sheetal Kassim, Roger Paredes, et al.
Science Translational Medicine|October 25, 2023
Genetic vulnerability to Crohn's disease reveals a spatially resolved epithelial restitution programToru Nakata, Chenhao Li, Toufic Mayassi, et al.
Pageof 103